Records collected on Tuesday, September 8, 2026

26 records, grouped by source. Every entry links to the official source.

← Sep 7, 2026 · Sep 9, 2026 →

Company filings on SEC EDGAR 4

• QUALCOMM INC/DE Sep 8, 2026 · Form 8-K (company current report)
• Veradigm Inc. Sep 8, 2026 · Form 8-K (company current report)
• GoPro, Inc. Sep 8, 2026 · Form 8-K (company current report)
• PDS Biotechnology Corp Sep 8, 2026 · Form 8-K (company current report)

U.S. Food and Drug Administration 19

• FDA Class II: ACCORD HEALTHCARE, INC. — Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), packaged in a) 90-count bottles (NDC 16729-457 Sep 2, 2026 · FDA enforcement report entry
• FDA Class II: Hikma Pharmaceuticals USA INC. — Ramipril Capsules USP, 10 mg, packaged in a) 100 Capsules (NDC 76282-673-01) and b) 500 Capsules (ND Sep 2, 2026 · FDA enforcement report entry
• FDA Class II: ACCORD HEALTHCARE, INC. — Levothyroxine Sodium Tablets, USP, 50 mcg (0.05 mg), 1000-count bottles, Rx Only, Manufactured for: Sep 2, 2026 · FDA enforcement report entry
• FDA Class II: ACCORD HEALTHCARE, INC. — Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 1000-count bottles, Rx Only, Manufactured for Sep 2, 2026 · FDA enforcement report entry
• FDA Class II: ACCORD HEALTHCARE, INC. — Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 1000-count bottles, Rx Only, Manufactured for: Sep 2, 2026 · FDA enforcement report entry
• FDA Class II: ACCORD HEALTHCARE, INC. — Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), packaged in a) 90-count bottles (NDC 16729-45 Sep 2, 2026 · FDA enforcement report entry
• FDA Class II: Lupin Pharmaceuticals Inc. — Clobetasol Propionate Cream USP, 0.05%, 60 g tube, Rx Only, Manufactured for: Lupin Pharmaceuticals Sep 2, 2026 · FDA enforcement report entry
• FDA Class II: ACCORD HEALTHCARE, INC. — Levothyroxine Sodium Tablets, USP, 300 mcg (0.3 mg), 90-count bottles, Rx Only, Manufactured for: Ac Sep 2, 2026 · FDA enforcement report entry
• FDA Class II: ACCORD HEALTHCARE, INC. — Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 1000-count bottles, Rx Only, Manufactured for: Sep 2, 2026 · FDA enforcement report entry
• FDA Class II: Mallinckrodt Hospital Products Inc. — Acthar Gel (repository corticotropin injection), 5 mL multiple-dose vial, Rx Only, Mfd. for: Mallinc Sep 2, 2026 · FDA enforcement report entry
• FDA Class II: ACCORD HEALTHCARE, INC. — Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), 1000-count bottles, Rx Only, Manufactured for: Sep 2, 2026 · FDA enforcement report entry
• FDA Class II: Church & Dwight Co., Inc. — Zicam, Cold Remedy, Medicated Nasal Swabs, With Cooling Menthol & Eucalyptus, 20 Single-Use Swabs pe Sep 2, 2026 · FDA enforcement report entry
• FDA Class II: ACCORD HEALTHCARE, INC. — Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), packaged in a) 90-count bottles (NDC 16729-45 Sep 2, 2026 · FDA enforcement report entry
• FDA Class I: Fresenius Kabi USA, LLC — Tyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx Only, Manufactured by Sep 2, 2026 · FDA enforcement report entry
• FDA Class I: B BRAUN MEDICAL INC — Lactated Ringer's Injection USP, 1000 mL EXCEL container, Rx only, L7500, B. Braun Medical, Inc., Be Sep 2, 2026 · FDA enforcement report entry
• FDA Class II: ACCORD HEALTHCARE, INC. — Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), packaged in a) 90-count bottles (NDC 16729-451- Sep 2, 2026 · FDA enforcement report entry
• FDA Class II: ACCORD HEALTHCARE, INC. — Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 1000-count bottles, Rx Only, Manufactured for: Sep 2, 2026 · FDA enforcement report entry
• FDA Class II: ACCORD HEALTHCARE, INC. — Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 1000-count bottles, Rx Only, Manufactured for Sep 2, 2026 · FDA enforcement report entry
• FDA Class II: Apotex Corp. — Paxil CR, Paroxetine, Extended-Release Tablets, 37.5mg, 30 count bottle, Rx only, Manufactured by: A Sep 2, 2026 · FDA enforcement report entry

Federal and state courts (via CourtListener) 3

• Salguero-Arriaza v. Navarijo-Davila Sep 8, 2026 · Court opinion
• Tschummi v. Fegan Sep 8, 2026 · Court opinion
• Villao v. Paz Sep 8, 2026 · Court opinion